8-K: American Shared Hospital Services Reports Strong FY 2024 Results, Appoints New CEO

American Shared Hospital Services announces a 32.9% increase in revenue for FY 2024 and the appointment of Gary Delanois as CEO, effective April 3, 2025.

Summary

• American Shared Hospital Services (AMS) reported its financial results for the fourth quarter and full year ended December 31, 2024.
• For FY 2024, revenue increased by 32.9% to $28.34 million compared to $21.325 million in 2023.
• Direct patient services revenue saw a significant increase of 253.4%, reaching $12.556 million.
• Leasing segment revenue decreased by 12.1% to $15.629 million.
• Proton therapy revenue decreased slightly by 1.8% to $9.952 million with 5,139 treatments.
• Net income attributable to AMS increased by 258.4% to $2.186 million, or $0.34 per diluted share.
• Adjusted EBITDA increased by 8.5% to $8.885 million.
• For Q4 2024, revenue increased by 59.2% to $9.069 million.
• The company reported a net loss of $1.308 million, or $0.20 per share, for Q4 2024.
• Gary Delanois has been appointed as the new CEO, effective April 3, 2025, while Raymond Stachowiak will continue as Executive Chairman of the Board.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth and increased profitability, along with a strategic leadership transition. However, some concerns remain regarding the leasing segment and Q4 losses.

Positives

• Significant revenue growth of 32.9% for FY 2024.
• Substantial increase in direct patient services revenue, up by 253.4%.
• Net income attributable to AMS increased significantly by 258.4%.
• Adjusted EBITDA increased by 8.5% for the year.
• Appointment of Gary Delanois as CEO to lead the next phase of growth.

Negatives

• Leasing segment revenue decreased by 12.1% for FY 2024.
• Proton therapy revenue saw a slight decrease of 1.8% for the year.
• The company reported a net loss of $1.308 million for Q4 2024.
• Gross margin declined slightly due to higher operating costs in the direct patient services segment.

Risks

• Economic and market conditions could impact future performance.
• Variability of financial results between quarters poses a risk.
• Changes to CMS reimbursement rates or methodology could affect revenue.
• The integration and operation of acquired businesses could adversely affect financial results.
• Current and future acquisitions may negatively affect the company's financial position.

Future Outlook

The company is focused on driving operational efficiencies, expanding health system partnerships, and capitalizing on new business development opportunities to drive continued business growth and long-term success.

Management Comments

• Ray Stachowiak stated that the company is pleased with its continued strong revenue growth and the successful integration of new facilities.
• Gary Delanois added that the company's growth strategy is delivering tangible results and they are excited about the momentum they are building.

Industry Context

AMS is transitioning from a traditional leasing model to a direct provider of radiation therapy treatment services, aligning with the industry trend of integrated cancer care and increased patient volumes.

Comparison to Industry Standards

• Comparing AMS's revenue growth of 32.9% to other companies in the medical equipment and services industry, such as Varian Medical Systems (now Siemens Healthineers) and Accuray Incorporated, would provide a benchmark for assessing its performance.
• The 253.4% increase in direct patient services revenue indicates a successful shift towards direct patient care, which is a growing trend in the healthcare industry.
• The adjusted EBITDA growth of 8.5% can be compared to the average EBITDA growth of similar-sized companies in the healthcare sector to evaluate its profitability.

Management Changes

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and leadership transition.
• Employees may experience changes as the company focuses on operational efficiencies and strategic initiatives.
• Customers (cancer treatment centers, health systems) can expect continued service and potential expansion of services.
• Suppliers may see increased demand as the company expands its operations.
• Creditors will likely view the company's financial stability favorably.

Next Steps

• The company plans to capitalize on new business development opportunities.
• AMS will focus on driving operational efficiencies and expanding health system partnerships.
• The company will continue to implement targeted strategic initiatives to improve efficiency and maximize profitability.

Key Dates

Keywords

American Shared Hospital Services, Financial Results, CEO Appointment, Revenue Growth, Direct Patient Services, Leasing, Proton Therapy, Adjusted EBITDA, AMS